Highlights:
• Metallurgical viability confirmed: Initial metallurgical test work confirms the feasibility of
employing acid leaching to beneficiate copper mineralisation discovered at the Ngami Copper
Project (NCP);
• Hydrogeological insights: Detailed review of the hydrogeology, including fracture distribution
logging and numerical modelling, demonstrates the laterally extensive mineralisation at NCP
satisfies key criteria required for In-Situ Copper Recovery (ISCR);
• Innovative cost-effective prospect: ISCR, if successful, provides an economically efficient
method for developing several tens of kilometres strike of moderate-grade copper mineralisation
at NCP, with minimal environmental impact and requiring low initial capital and operating
expenditures;
• Following the success of the first phase of metallurgical test work, where copper recovery rates
of 55.7% and 45.4% were achieved from moderate and high-grade composite samples
respectively, Cobre has initiated additional testing to optimise leaching conditions to further
increase copper recoveries;
• Further hydrogeological test work designed to prove the viability of ISCR will include a series of
pumping tests to provide an estimate of hydraulic conductivity and connectivity along the fracture
zones associated with mineralisation; and
• Release of Inferred Resource and Exploration Target Category modelling results, expected within
Q3 2023, will provide further insight into the project’s scale and potential avenues for expansion
at NCP.
- Forums
- ASX - By Stock
- CBE
- Ann: Potential for Extensive In-Situ Copper Mining - Botswana
CBE
cobre limited
Add to My Watchlist
8.70%
!
4.2¢

Ann: Potential for Extensive In-Situ Copper Mining - Botswana, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.2¢ |
Change
-0.004(8.70%) |
Mkt cap ! $18.62M |
Open | High | Low | Value | Volume |
4.8¢ | 4.8¢ | 4.1¢ | $33.92K | 752.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 55302 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 82052 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 55302 | 0.041 |
4 | 231186 | 0.040 |
4 | 475426 | 0.039 |
6 | 1561529 | 0.038 |
2 | 320270 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 82052 | 2 |
0.045 | 100000 | 1 |
0.046 | 100000 | 2 |
0.047 | 100000 | 1 |
0.048 | 349705 | 2 |
Last trade - 11.10am 01/08/2025 (20 minute delay) ? |
Featured News
CBE (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
SPONSORED BY The Market Online